Search research articles
Contact Us
Filters
Showing results (131-140 of 173) with videos related to
Page
of 18
Sort By:
Molecular Cancer Therapeutics
|
August 28, 2020
Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062)
Krishnansu S Tewari, Michael W Sill, Bradley J Monk, et al.
JCO Precision Oncology
|
September 14, 2020
Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials
Rodrigo Dienstmann, Elena Garralda, Susana Aguilar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 13, 2021
Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials
Ignacio Matos, Guillermo Villacampa, Cinta Hierro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2025
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201
Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian, et al.
The Lancet. Oncology
|
May 4, 2020
Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial
Jonathan A Ledermann, Amit M Oza, Domenica Lorusso, et al.
Cancer Medicine
|
September 22, 2021
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety
Ana Oaknin, Amit M Oza, Domenica Lorusso, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 19, 2023
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023
David Cibula, Maria Rosaria Raspollini, François Planchamp, et al.
Gynecologic Oncology
|
March 23, 2021
Population exposure-efficacy and exposure-safety analyses for rucaparib in patients with recurrent ovarian carcinoma from Study 10 and ARIEL2
Gottfried E Konecny, Amit M Oza, Anna V Tinker, et al.
Journal of Personalized Medicine
|
December 29, 2022
Laboratory Cross-Comparison and Ring Test Trial for Tumor <i>BRCA</i> Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study
Zaida Garcia-Casado, Ana Oaknin, Marta Mendiola, et al.
Gynecologic Oncology
|
August 31, 2020
The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma
Nicoletta Colombo, Amit M Oza, Domenica Lorusso, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 173) with videos related to
Sort By:
Page
of 18
Molecular Cancer Therapeutics
|
August 28, 2020
Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062)
Krishnansu S Tewari, Michael W Sill, Bradley J Monk, et al.
JCO Precision Oncology
|
September 14, 2020
Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials
Rodrigo Dienstmann, Elena Garralda, Susana Aguilar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 13, 2021
Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials
Ignacio Matos, Guillermo Villacampa, Cinta Hierro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2025
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201
Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian, et al.
The Lancet. Oncology
|
May 4, 2020
Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial
Jonathan A Ledermann, Amit M Oza, Domenica Lorusso, et al.
Cancer Medicine
|
September 22, 2021
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety
Ana Oaknin, Amit M Oza, Domenica Lorusso, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 19, 2023
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023
David Cibula, Maria Rosaria Raspollini, François Planchamp, et al.
Gynecologic Oncology
|
March 23, 2021
Population exposure-efficacy and exposure-safety analyses for rucaparib in patients with recurrent ovarian carcinoma from Study 10 and ARIEL2
Gottfried E Konecny, Amit M Oza, Anna V Tinker, et al.
Journal of Personalized Medicine
|
December 29, 2022
Laboratory Cross-Comparison and Ring Test Trial for Tumor <i>BRCA</i> Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study
Zaida Garcia-Casado, Ana Oaknin, Marta Mendiola, et al.
Gynecologic Oncology
|
August 31, 2020
The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma
Nicoletta Colombo, Amit M Oza, Domenica Lorusso, et al.
Page
of 18